ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01039207
Brief Title: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

First Submitted : December 22, 2009
First Submitted that Met QC Criteria : December 22, 2009
First Posted : December 24, 2009 (Estimate)

Results First Submitted : August 8, 2017
Results First Submitted that Met QC Criteria : August 8, 2017
Results First Posted : September 7, 2017

Last Update Submitted that Met QC Criteria : August 8, 2017
Last Update Posted : September 7, 2017